163 related articles for article (PubMed ID: 31857038)
1. Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation.
Romero J; Cerrud-Rodriguez RC; Alviz I; Diaz JC; Rodriguez D; Arshad S; Cerna L; Taveras J; Grupposo V; Natale A; Garcia M; Di Biase L
JACC Clin Electrophysiol; 2019 Dec; 5(12):1396-1405. PubMed ID: 31857038
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.
Santarpia G; De Rosa S; Polimeni A; Giampà S; Micieli M; Curcio A; Indolfi C
PLoS One; 2015; 10(5):e0126512. PubMed ID: 25974377
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials.
de Lucena LA; Freitas MAA; Souza AKC; Silva CHA; Watanabe JMF; Guedes FL; Almeida JB; de Oliveira RA
J Thromb Thrombolysis; 2024 Mar; 57(3):381-389. PubMed ID: 38281231
[TBL] [Abstract][Full Text] [Related]
4. Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation.
Yang P; Wang C; Ye Y; Huang T; Yang S; Shen W; Xu G; Wu Q
Cardiovasc Drugs Ther; 2020 Jun; 34(3):371-381. PubMed ID: 32232617
[TBL] [Abstract][Full Text] [Related]
5. Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation.
De Heide J; Vroegh CJ; Bhagwandien RE; Wijchers SA; Szili-Torok T; Zijlstra F; Lenzen MJ; Yap SC
J Interv Card Electrophysiol; 2018 Dec; 53(3):341-346. PubMed ID: 30074120
[TBL] [Abstract][Full Text] [Related]
6. Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.
Bawazeer GA; Alkofide HA; Alsharafi AA; Babakr NO; Altorkistani AM; Kashour TS; Miligkos M; AlFaleh KM; Al-Ansary LA
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013504. PubMed ID: 34674223
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis.
Kyriakoulis I; Adamou A; Stamatiou I; Chlorogiannis DD; Kardoutsos I; Koukousaki D; Ntaios G
Eur J Intern Med; 2024 Jan; 119():45-52. PubMed ID: 37648582
[TBL] [Abstract][Full Text] [Related]
8. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
Hu T; Li YH; Han WQ; Maduray K; Chen TS; Hao L; Zhong JQ
Am J Cardiovasc Drugs; 2023 Nov; 23(6):683-694. PubMed ID: 37639201
[TBL] [Abstract][Full Text] [Related]
9. Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists.
Troisi F; Guida P; Vitulano N; Quadrini F; Di Monaco A; Patti G; Grimaldi M
Am J Cardiol; 2024 May; 218():77-85. PubMed ID: 38458580
[TBL] [Abstract][Full Text] [Related]
10. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation on chronic hemodialysis: a meta-analysis of randomized controlled trials.
Navalha DDP; Felix N; Nogueira A; Clemente M; Marinho AD; Ferreira ROM; Pasqualotto E; Dagostin CS; Pinto LCS; Fernandes GC
Int Urol Nephrol; 2024 Jun; 56(6):2001-2010. PubMed ID: 38153665
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of direct oral anticoagulants and vitamin K antagonists for left ventricular thrombus: Systematic review and meta-analysis.
Kitano T; Nabeshima Y; Kataoka M; Takeuchi M
PLoS One; 2021; 16(7):e0255280. PubMed ID: 34310654
[TBL] [Abstract][Full Text] [Related]
12. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials.
Khairani CD; Bejjani A; Piazza G; Jimenez D; Monreal M; Chatterjee S; Pengo V; Woller SC; Cortes-Hernandez J; Connors JM; Kanthi Y; Krumholz HM; Middeldorp S; Falanga A; Cushman M; Goldhaber SZ; Garcia DA; Bikdeli B
J Am Coll Cardiol; 2023 Jan; 81(1):16-30. PubMed ID: 36328154
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus.
Huang L; Tan Y; Pan Y
ESC Heart Fail; 2022 Oct; 9(5):3519-3532. PubMed ID: 35894752
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists.
Tscharre M; Steiner D; Mutschlechner D; Ay C; Gremmel T
Res Pract Thromb Haemost; 2024 Jan; 8(1):102332. PubMed ID: 38404942
[TBL] [Abstract][Full Text] [Related]
15. Catheter ablation for atrial fibrillation on uninterrupted direct oral anticoagulants: A safe approach.
Sawhney V; Shaukat M; Volkova E; Jones N; Providencia R; Honarbakhsh S; Dhillon G; Chow A; Lowe M; Lambiase PD; Dhinoja M; Sporton S; Earley MJ; Schilling RJ; Hunter RJ
Pacing Clin Electrophysiol; 2018 May; ():. PubMed ID: 29768672
[TBL] [Abstract][Full Text] [Related]
16. Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence.
Hajra A; Ujjawal A; Ghalib N; Chowdhury S; Biswas S; Balasubramanian P; Gupta R; Aronow WS
Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102017. PubMed ID: 37544618
[TBL] [Abstract][Full Text] [Related]
17. Unresolved issues in the use of direct acting oral anticoagulants.
Chan N; Hirsh J
Expert Rev Cardiovasc Ther; 2023; 21(12):913-921. PubMed ID: 37837206
[TBL] [Abstract][Full Text] [Related]
18. DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study.
Creta A; Ventrella N; Earley MJ; Finlay M; Sporton S; Maclean E; Kanthasamy V; Lemos Silva Di Nubila BC; Ricciardi D; Calabrese V; Picarelli F; Hunter RJ; Lambiase PD; Schilling RJ; Grigioni F; Monkhouse C; Muthumala A; Moore P; Providencia R; Chow A
JACC Clin Electrophysiol; 2024 Jan; 10(1):121-132. PubMed ID: 37897463
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of direct oral anticoagulants compared to Vitamin K antagonists postpercutaneous coronary interventions in patients with atrial fibrillation: A systematic review and meta-analysis.
Agasthi P; Lee JZ; Pujari SH; Tseng AS; Shipman J; Almader-Douglas D; Ashraf H; Mookadam F; Fortuin FD; Beohar N; Arsanjani R; Mulpuru S
J Arrhythm; 2020 Apr; 36(2):271-279. PubMed ID: 32256873
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness and safety of DOACs vs. VKAs in treatment of left ventricular thrombus- a meta-analysis update.
Hu T; Chen C; Maduray K; Han W; Chen T; Zhong J
Thromb J; 2024 Mar; 22(1):23. PubMed ID: 38429631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
